Efficacy and Tolerability of Long-Acting Injectable Naltrexone for Alcohol Dependence
JAMAPublished 6 April 2005
James C. Garbutt, Henry R. Kranzler, Stephanie S. O’Malley, David R. Gastfriend, Helen M. Pettinati, Bernard L. Silverman
Citations612
SJR quartileQ1
SJR score5.35
SNIP10.71
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
Abstract
Long-acting naltrexone was well tolerated and resulted in reductions in heavy drinking among treatment-seeking alcohol-dependent patients during 6 months of therapy. These data indicate that long-acting naltrexone can be of benefit in the treatment of alcohol dependence.
Keywords
Medicine
Macat Library eBooksThe Structure of Scientific Revolutions
5,423 Citations2017Jo Hedesan, Joseph Tendler
JAMADrug Dependence, a Chronic Medical Illness
2,588 Citations2000A. Thomas McLellan, D. C. Lewis +2 more
Evidence that drug (including alcohol) dependence is a chronic medical illness is examined and results suggest that long-term care strategies of medication management and continued monitoring produce lasting benefits.
BiometricsSequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial
2,302 Citations1975Stuart Pocock, Richard Simon
A new general procedure for treatment assignment is described which concentrates on minimizing imbalance in the distributions of treatment numbers within the levels of each individual prognostic factor.
Archives of General PsychiatryNaltrexone in the Treatment of Alcohol Dependence
1,856 Citations1992Joseph R. Volpicelli
Naltrexone may be a safe and effective adjunct to treatment in alcohol-dependent subjects, particularly in preventing alcohol relapse, and was seen in patients who drank any alcohol while attending outpatient treatment.
Archives of General PsychiatryNaltrexone and Coping Skills Therapy for Alcohol Dependence
1,503 Citations1992Stephanie S. O’Malley
Naltrexone proved superior to placebo in measures of drinking and alcohol- related problems, including abstention rates, number of drinking days, relapse, and severity of alcohol-related problems.
Preventive MedicineA meta-analysis of alcohol consumption and the risk of 15 diseases
1,098 Citations2004Giovanni Corrao
This meta-analysis shows no evidence of a threshold effect for both neoplasms and several non-neoplastic diseases, and J-shaped relations were observed only for coronary heart disease.
Journal of the Royal Statistical Society Series B (Statistical Methodology)Semiparametric Regression for the Mean and Rate Functions of Recurrent Events
942 Citations2000D. Y. Lin, L. J. Wei +2 more
The Cochrane Database of Systematic ReviewsOpioid antagonists for alcohol dependence
766 Citations2002Manit Srisurapanont, Ngamwong Jarusuraisin
NTX at the dose of 50 mg/day is effective for alcohol dependence in short-term treatment, and other opioid antagonists with/without other biological or psychosocial treatments were examined.
Alcoholism Clinical and Experimental ResearchAlcoholism: Allostasis and Beyond
745 Citations2003George F. Koob
The allostatic model not only integrates molecular, cellular, and circuitry neuroadaptations in brain motivational systems produced by chronic alcohol ingestion with genetic vulnerability but also provides a key to translate advances in animal studies to the human condition.
New England Journal of MedicineNaltrexone in the Treatment of Alcohol Dependence
614 Citations2001John Krystal, Joyce A. Cramer +3 more
The findings do not support the use of naltrexone for the treatment of men with chronic, severe alcohol dependence.
AddictionEfficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review
508 Citations2004Bouza Carmen, Angeles Magro +2 more
Both acamprosate and naltrexone are effective as adjuvant therapies for alcohol dependence in adults and both drugs are safe and acceptably tolerated but issues of compliance need to be addressed adequately to assure their usefulness in clinical practice.
Journal of the American College of CardiologyDiagnostic value of history in patients with syncope with or without heart disease
449 Citations2001Paoló Alboni, Michele Brignole +6 more
The presence of suspected or certain heart disease after the initial evaluation is a strong predictor of a cardiac cause of syncope in patients with and without heart disease.
American Journal of PsychiatryNaltrexone and Cognitive Behavioral Therapy for the Treatment of Outpatient Alcoholics: Results of a Placebo-Controlled Trial
430 Citations1999Raymond F. Anton, Darlene H. Moak +4 more
Motivated individuals with moderate alcohol dependence can be treated with greater effectiveness when naltrexone is used in conjunction with weekly outpatient cognitive behavioral therapy.
Archives of General PsychiatryNaltrexone and Alcohol Dependence
420 Citations1997Joseph R. Volpicelli
Naltrexone is clinically effective relative to placebo in individuals who comply with the treatment protocol and take medication in a more naturalistic setting with respect to the role of treatment attendance and medication compliance.
Statistics in MedicineHandling drop‐out in longitudinal studies
403 Citations2004Joseph W. Hogan, Jason Roy +1 more
This tutorial is designed to synthesize and illustrate the broad array of techniques that are used to address outcome‐related drop‐out, with emphasis on regression‐based methods.
Alcoholism Clinical and Experimental ResearchEfficacy of Naltrexone and Acamprosate for Alcoholism Treatment: A Meta‐Analysis
393 Citations2001Henry R. Kranzler, Jeffrey Van Kirk
Both naltrexone and acamprosate are efficacious in reducing alcohol consumption in alcoholics, however, their specific role in alcoholism treatment remains to be more clearly defined.
Alcohol and AlcoholismA MULTICENTRE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF NALTREXONE IN THE TREATMENT OF ALCOHOL DEPENDENCE OR ABUSE
318 Citations2000Jonathan Chick
Naltrexone is effective in treating alcohol dependence/abuse in conjunction with psychosocial therapy, in patients who comply with treatment.
Clinical Pharmacology & TherapeuticsNaltrexone: Disposition, metabolism, and effects after acute and chronic dosing
274 Citations1976Karl Verebey, Jan Volavka +2 more
New England Journal of MedicinePatients with Alcohol Problems
271 Citations1998Patrick G. O’Connor, Richard S. Schottenfeld
The term “alcohol problems” (problems caused by alcohol that may require treatment) refers to a broad array of acute and chronic medical, behavioral, and social problems that may affect their patients.
Alcoholism Clinical and Experimental ResearchNaltrexone and Cue Exposure With Coping and Communication Skills Training for Alcoholics: Treatment Process and 1‐Year Outcomes
237 Citations2001Peter M. Monti, Damaris J. Rohsenow +9 more
The results suggest the probable value of keeping alcoholics on NTX for longer periods of time and the importance of increasing compliance with NTX and support the earlier promising effects of CET and CST as adjuncts to treatment programs for alcoholics by maintaining treatment gains over at least a year.
Alcohol and AlcoholismNALTREXONE, A RELAPSE PREVENTION MAINTENANCE TREATMENT OF ALCOHOL DEPENDENCE: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
230 Citations2001Catherine L. Streeton
The meta-analysis of benefit indicates that naltrexone is superior to placebo, and there is no significant difference between nALTrexone and placebo in terms of the number of subjects with at least one adverse event or the numberof subjects who discontinued the trial due to an adverse event.
NeuropsychopharmacologyNaltrexone vs. Nefazodone for Treatment of Alcohol Dependence A Placebo-Controlled Trial
211 Citations2000Henry R. Kranzler
The results indicate that nefazodone is not efficacious for treatment of alcohol dependence, and the clinical utility of naltrexone seems to be limited by its adverse effects, a finding that has important implications for efforts to develop medications to treat alcohol dependence.
Proceedings of the Association of American PhysiciansMortality and Morbidity Attributable to Use of Addictive Substances in the United States
186 Citations1999J. Michael McGinnis, William H. Foege
Combined, the effects of tobacco, alcohol, and drugs inflict a greater toll on the health and well-being of Americans than any other single preventable factor.
Alcoholism Clinical and Experimental ResearchEffects of Naltrexone on Alcohol Self‐Administration in Heavy Drinkers
171 Citations1999Dena Davidson, Tibor P. Palfai +2 more
The results of this study suggest that NTX affects a number of the components of alcohol drinking sequence, including lowering cravings, decreasing the positive reinforcing effects of alcohol, and increasing headache and nausea, each of which may contribute to reducing alcohol intake.
Alcoholism Clinical and Experimental ResearchNaltrexone Depot for Treatment of Alcohol Dependence: A Multicenter, Randomized, Placebo‐Controlled Clinical Trial
168 Citations2004Henry R. Kranzler, Donald R. Wesson +2 more
This is the first multicenter study of a depot formulation of naltrexone for the treatment of alcohol dependence and using a conservative intent-to-treat analysis, the study showed an advantage for the active medication.
Archives of Internal MedicineInitial and Maintenance Naltrexone Treatment for Alcohol Dependence Using Primary Care vs Specialty Care
143 Citations2003Stephanie S. O’Malley, Bruce J. Rounsaville +5 more
Maintenance of improvement was enhanced by continued naltrexone treatment in the PCM but not in the CBT arm, and comparable results during the initial 10 weeks of treatment when combined with PCM or CBT.
Journal of Addictive DiseasesImproving Naltrexone Response
124 Citations2000Helen M. Pettinati, Joseph R. Volpicelli +2 more
Support is provided for the use of an intervention that targets medication compliance when prescribing nal-trexone, a FDA-approved medication for alcohol dependence, if it is supported and help patients to consistently take their medication.
Drug and Alcohol DependenceUnderstanding US addiction physicians' low rate of naltrexone prescription
120 Citations2003Tami L. Mark
Multivariate results indicated that physician perceptions of naltrexone's effectiveness and safety were significantly associated with prescribing, and physicians who had more exposure to information about the product were more likely to prescribe it.
Alcoholism Clinical and Experimental ResearchSustained‐Release Naltrexone for Alcoholism Treatment: A Preliminary Study
119 Citations1998Henry R. Kranzler, Vania Modesto‐Lowe +1 more
The potential clinical utility of the SRP of NTX for treatment of alcohol dependence is supported and the frequency of heavy drinking days during the Injection and Follow-up Periods is significantly reduced.
Journal of NeuropsychiatryAddiction Denial and Cognitive Dysfunction
118 Citations2002William E. Rinn, Nitigna Desai +2 more
The proposition that denial of addiction is often more a product of cognitive failure due to cerebral dysfunction than an emotion-driven rejection of the truth is explored.
American Journal on AddictionsPharmacological Mechanisms of Naltrexone and Acamprosate in the Prevention of Relapse in Alcohol Dependence
110 Citations2003John M. Littleton, W. Zieglgänsberger
Naltrexone and acamprosate may ultimately prove to be useful additions to pharmacotherapy for alcoholism by reducing relapse by inhibits the glutamatergic transmitter system involved in both the negative reinforcing effects of alcohol and the conditioned "pseudo-withdrawal" that may be important in cue-induced relapse.
Addictive BehaviorsEvaluating multiple outcomes and gender differences in alcoholism treatment
84 Citations1995Kathleen M. Schneider, Frederick J. Kviz +2 more
Evidence that women and men have different post-treatment functioning, and that different characteristics are predictive of these outcomes, is evidence that the process of recovery is not the same for both genders.
British Journal of AddictionSuperior Outcome of Females Over Males After Brief Treatment for the Reduction of Heavy Drinking
83 Citations1989Martha Sanchez‐Craig, Gillian Leigh +2 more
Females were more successful than males in all conditions and mean changes in GGT and MCV levels lended support to the change in drinking status (from heavy drinker at intake to moderate drinkers at follow-up), based on clients' self-reports.
Alcoholism Clinical and Experimental ResearchA Pilot Evaluation of the Safety and Tolerability of Repeat Dose Administration of Long‐Acting Injectable Naltrexone (Vivitrex®) in Patients With Alcohol Dependence
81 Citations2004Bankole A. Johnson, Nassima Ait‐Daoud +6 more
The results of this pilot study provide the basis and methods for a larger, more definitive trial to determine the utility of this long-acting injectable naltrexone formulation in the treatment of alcohol-dependent patients.
Scientific Repository (Petra Christian University)Combining Medication and Psychosocial Treatments for Addictions: The BRENDA Approach
69 Citations2001Joseph R. Volpicelli, Helen M. Pettinati +2 more
NeuropsychopharmacologyVivitrex®, an Injectable, Extended-Release Formulation of Naltrexone, Provides Pharmacokinetic and Pharmacodynamic Evidence of Efficacy for 1 Month in Rats
66 Citations2003Raymond T. Bartus, Dwaine F. Emerich +5 more
Data suggest that therapeutically relevant plasma levels of naltrexone can be maintained using monthly injections of an extended-release microsphere formulation, and that changes in μ-opioid receptor density do not impact its efficacy in suppressing morphine-induced analgesia in the rat.
NeuropsychopharmacologyNaltrexone Dampens Ethanol-Induced Cardiovascular and Hypothalamic- Pituitary-Adrenal Axis Activation
65 Citations2001Mary E. McCaul
Naltrexone significantly dampened alcohol-induced increases in heart rate, diastolic blood pressure, hormone levels and subjective liking of drink effects, and this dampening of cardiovascular and hormonal responses may contribute to the therapeutic effectiveness of naltrexones for reducing alcohol liking and decreasing relapse in alcohol-dependent persons.
PubMedMedications and alcohol craving.
62 Citations1999Robert M. Swift
The use of medications as an adjunct to alcoholism treatment is based on the premise that craving and other manifestations of alcoholism are mediated by neurobiological mechanisms, and three of the four medications approved in the United States or Europe are reported to reduce craving.
Drug and Alcohol DependenceClinical evaluation of a naltrexone sustained-release preparation
54 Citations1985C. Nora Chiang, Leo E. Hollister +2 more
Opiate effects of morphine challenges were mitigated during the 2-4-week period after administration of naltrexone beads, and an average of 2.4-2.7% of implanted dose was absorbed each day from the administration of the beads.
Alcoholism Clinical and Experimental ResearchShort of Complete Abstinence: An Analysis Exploration of Multiple Drinking Episodes in Alcoholism Treatment Trials
32 Citations2002Sue‐Jane Wang, Cellia J. Winchell +3 more
The multiple failure time approach may be applicable when 'drinking failure' is variously defined as a single drink, one at-risk drinking day, one heavy drinking days, or one alcohol-related social, occupational or medical problem.
Journal of Substance AbuseAlternative measures and models of hazardous consumption
19 Citations2000Deborah A. Dawson
There was no consistent evidence for one approach being superior to the other as a predictor of acute alcohol-related outcomes, and models using combinations of simple, easy-to-obtain measures performed nearly on a par with those utilizing far more complex measures.